Perelman School of Medicine

An immunotherapy strategy against all blood cancers

Researchers at Penn Medicine have demonstrated a new potential treatment using CAR T cell therapy using a CRISPR base-editing to develop a method called “epitope editing.”

From Penn Medicine News



In the News


Philadelphia Inquirer

Scholars at risk in their own countries find a new home at Penn

Penn Global’s Scholars-at-Risk program is featured. Global’s Ezekiel J. Emanuel and Scott Moore, Penn Carey Law’s Eric Feldman, and Wharton’s Jesús Fernández-Villaverde, along with former and current scholars Angel Alvarado, Pavel Golubev, and Jawad Moradi are interviewed.

FULL STORY →



Newsweek

Sugar-coated gold nanoparticles could replace some antibiotics

According to a Penn Medicine study, a new therapy involving laser light and sugar-coated gold nanoparticles can reduce tooth decay and infected wounds without needing antibiotics.

FULL STORY →



Associated Press

A new strategy to attack aggressive brain cancer shrank tumors in two early tests

A clinical trial led by Stephen Bagley of the Perelman School of Medicine suggests that targeting two associated proteins with CAR T cell therapy could be a viable strategy for shrinking brain tumors.

FULL STORY →



New Scientist

Alzheimer’s may be caused by a build-up of fat in brain cells

A study by Michael Haney of the Perelman School of Medicine suggests that the root cause of Alzheimer’s is a build-up of fat droplets in brain cells.

FULL STORY →



WHYY (Philadelphia)

Philadelphia hospital program adds psychologists to bridge mental health services for trauma survivors

A new psychology team at the Penn Trauma Violence Recovery Program has provided about 46 survivors with short- and long- term therapy, featuring remarks from Elinore Kaufman and Lily Brown of the Perelman School of Medicine.

FULL STORY →